The FDA hosted a PSC Workshop on March 3rd – 4th, 2016, in Silver Spring, Maryland. The topic of the conference was Trial Design and Endpoints for Clinical Trial in Adults and Children with Primary Sclerosing Cholangitis. The FDA workshop was also sponsored by AASLD, ACG, AGA and NASPGHAN.
Video of the workshop is now available to stream online. If you were unable to attend the workshop in person, or missed part of the live webcast, there are two ways to view the material. The AASLD website has posted the entire workshop in separate segments, which is easier to navigate, whereas the FDA website allows viewers to stream the workshop in its entirety.
Presentations explaining the patient perspective were made by Ricky Safer, CEO of PSC Partners, and Martine Walmsley, Chair of PSC Support in the UK, and can be found in Session III: Patient Experience. The workshop demonstrates the dynamic state of PSC research: as collaboration increases among stakeholders who search for a cure for PSC, the patient voice is more important now than ever before.
